质子抑制剂和血液感染的风险没有可识别的来源:一个医院的病例控制研究
Shintaro Hayashi1, Tomohito Moriyama1, Yuichiro Ito1
1Department of Gastroenterology, Ichinomiya Nishi Hospital, Japan.
Japanese journal of infectious diseases
|January 31, 2024
概括
质子抑制剂 (PPI) 的使用与更高的血流感染 (BSI) 风险有关,没有明确的来源. 这表明,由于细菌转移,PPI可能会增加BSI的可能性.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 质子抑制剂 (PPI) 使用与细菌转位引起的全身感染之间的联系仍然不确定.
- 在接受PPI治疗的患者中,调查血液感染 (BSI) 的潜在风险增加至关重要.
研究的目的:
- 为了确定使用PPI的患者是否有更大的风险发展血液感染 (BSI) 没有可识别的来源.
- 探索PPI治疗与细菌转位型 (BT型) BSI之间的关联.
主要方法:
- 在2019年,一项基于医院的病例控制研究在Ichinomiya Nishi医院进行.
- 包括20岁以上通过血液培养确认BSI的患者.
- 定义BT型BSI为没有可识别来源的感染;对照有来源的BSI.
主要成果:
- 分析了309名患者的数据 (66例,243例对照).
- 与非使用者相比,使用PPI的风险是BT型BSI的2.4倍 (aOR: 2.41,95%CI: 1.29-4.51,P = 0.006).
结论:
- 质子抑制剂的使用与血液感染的风险增加有关,缺乏可识别的来源.
- 研究结果表明,PPI可能会导致细菌转移导致BSI的风险增加.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
433
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
433
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
407
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
407
Peptic Ulcer Disease I: Introduction
168
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168
Peptic Ulcer Disease IV: Management
93
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
93
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
430
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
430
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
592
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
592


